Key takeaway: The study found an association, not proof that ADHD causes Alzheimer's disease or dementia. It does not establish a person's individual risk or show that changing ADHD treatment prevents cognitive impairment.
What did the researchers find?
A study published October 7, 2026 in JAMA Psychiatry analyzed electronic health records and genetic data from 187,341 adults aged 50 and older in the US All of Us Research Program. Of these participants, 3,026 had a recorded ADHD diagnosis. Researchers followed records for diagnoses of mild cognitive impairment (MCI) or dementia.
6.7% vs 3.4%
203 of 3,026 people with ADHD and 6,259 of 184,315 without a recorded ADHD diagnosis developed MCI or dementia in the study's record-based follow-up. These are observed group figures, not anyone's personal forecast.
Adjusted hazard ratio: 4.60
One adjusted time-to-event model found a higher hazard among participants with ADHD. A hazard ratio is not the same as saying any individual has a 460% probability of dementia, or that 4.6 times as many participants developed it.
Genetic analysis: a separate signal
Participants in the highest ADHD polygenic-risk group also had a higher recorded impairment risk than those in the lowest group (hazard ratio 1.35). Genetic association does not establish a direct disease mechanism or an individual's outcome.
What remains unknown
Researchers could not determine if ADHD treatment changes later cognitive outcomes. The reasons for the association—including differences in health, diagnosis, and shared risk factors—require additional research.
Why this is not proof of cause and effect
This was an observational analysis, not a randomized study. The authors discuss possible diagnostic misclassification, differences in healthcare access or contact, unmeasured confounding, and reverse causation: early cognitive problems may sometimes be mistaken for, or initially recorded as, ADHD. The association became smaller in analyses requiring longer gaps between ADHD diagnosis and cognitive impairment.
The cohort was drawn from a volunteer research program, and the genetic score had important ancestry limitations. The investigators call for further clinical research and development of monitoring guidelines; the paper does not itself create a new recommendation for routine dementia testing of every adult with ADHD.
What might be useful in everyday life?
ADHD can involve lifelong difficulties with working memory, organization, attention, and task initiation. A meaningful new decline in everyday abilities deserves individual attention, but ordinary ADHD symptoms alone should not be interpreted as dementia.
Notice what changed
Write down what has been present for years versus what is new, worsening, or interfering with daily independence. Give concrete examples rather than relying on a single memory lapse.
Review the broader picture
Discuss sleep, mood, anxiety, hearing, medications, substance use, and physical health with a clinician. These factors can affect how a person's attention or memory feels and functions.
Ask about appropriate evaluation
If cognitive changes are persistent or significant, a qualified professional can determine whether an assessment is warranted and how to distinguish different explanations.
Focus on support, not fear
Clear routines, accessible reminders, follow-up systems, and help with complex tasks may support daily participation regardless of the eventual clinical explanation.
Questions to take to a clinician
- Which attention or memory difficulties fit my established ADHD pattern, and which represent new changes?
- Could sleep, stress, depression, medications, or physical conditions be contributing?
- Would a cognitive evaluation be appropriate for my symptoms and history—and what would it involve?
- How should we monitor changes in everyday function without assuming an outcome?
- What evidence-based supports would improve my quality of life now?
About medication: This study did not establish that ADHD medications increase or decrease dementia risk. Do not start, stop, or change medications on the basis of this association.
Sources and editorial review
- Bauer-Negrini G, et al. Attention-Deficit/Hyperactivity Disorder and Late-Life Cognitive Impairment. JAMA Psychiatry. Published October 7, 2026.
- National Institute of Mental Health — ADHD overview and treatment context
Sources reviewed October 13, 2026. NeuroCoach provides educational context, not a diagnosis, individualized risk prediction, or a substitute for clinical advice. Independent clinical editorial review is pending.